A proprietary blend lists several ingredients under one combined weight without disclosing individual amounts. Ingredients must be listed in descending order by weight, which tells you the ranking but not the distribution — the first ingredient could be 90 percent of the blend. Undisclosed amounts have the same practical effect. Neither proves under-dosing, but both make verification impossible.
What a proprietary blend is
A proprietary blend groups multiple ingredients under a single line with one combined weight. You see "Cognitive Support Blend — 600 mg" followed by a list of eight names. You know the total. You do not know the split.
The justification offered is trade secrecy: a formulator has developed a specific ratio and does not want competitors copying it. That argument has some historical merit and considerably less than it is asked to carry, given that ingredient lists are public and analytical testing exists.
The one thing the ordering tells you
Ingredients within a blend must be listed in descending order by weight. That gives you a ranking, and a ranking is not nothing.
But consider what it permits. In a 600 mg blend of eight ingredients, the following is entirely legitimate: the first ingredient at 550 mg, and the remaining seven splitting 50 mg between them. The label would look identical to a blend distributing 75 mg to each.
The practical consequence is that the cheapest ingredient is very often the first-listed one, carrying the weight, while the expensive, well-researched actives at the end contribute milligrams. This is sometimes called label dressing, and the blend structure is what makes it undetectable.
Undisclosed amounts are the same problem
A label can also list ingredients individually with no amount at all — "Bacopa Monnieri" on its own line, no milligrams, no standardisation.
Structurally this is a different presentation of the same issue. You cannot compare the product to the research either way. Arguably it is worse, because a blend at least gives you a total and a ranking, whereas an undisclosed individual amount gives you neither.
This matters most when the undisclosed ingredients are the ones the product is sold on. A cognitive formula that prints exact amounts for its amino acids while leaving its botanicals unquantified has disclosed the parts that are cheap and withheld the parts that are expensive. That may be coincidence. It is worth noticing either way.
What you can still work out
Three deductions remain available even with an opaque label.
Total weight versus research doses. If a blend totals 600 mg and contains eight ingredients whose individual research doses run 200 to 500 mg each, the arithmetic is decisive: several must be well below research levels. The total constrains the possibilities.
Position of the ingredient you care about. If Bacopa is seventh of eight in a 400 mg blend, it is receiving a small fraction. Descending order guarantees that much.
Price relative to disclosure. A premium-priced product with an opaque panel is asking for more trust than a budget one. That is a fair thing to weigh.
The industry is moving, slowly
Consumer pressure has pushed a meaningful number of brands toward full disclosure, and "fully disclosed label" has become a marketing point in itself — which tells you buyers now recognise it as one.
The direct-response corner of the market, where products are sold through single order pages and paid traffic rather than retail shelves, has moved more slowly. Those buyers arrive from an advertisement rather than from a comparison, and comparison is what drives disclosure.
How to handle an opaque label
Two options, both reasonable.
Ask. Email the manufacturer and request the individual amounts in writing. A brand using research-relevant doses has every commercial reason to tell you — it is a selling point. A brand that declines, deflects or does not reply has answered a different question, and that answer is also useful.
Assume the low end. If you would still buy the product assuming each undisclosed ingredient sits at the bottom of its plausible range, buy it. If your willingness depends on those amounts being generous, do not buy until you have confirmed them.
That second rule is the practical one. It converts an unanswerable question into a decision you can actually make, and it protects you from paying premium prices for optimism.
Frequently asked
Are proprietary blends always bad?
Not always, but they are always a limitation. They prevent you from comparing the product to the published research, which is the only objective way to evaluate a formula. Some blends are well dosed. The problem is that you cannot distinguish those from poorly dosed ones, and the label structure is what prevents you.
How can I find out what is in a blend?
Email the manufacturer and ask for individual amounts in writing. Brands using research-relevant doses usually answer, because it is a selling point. If the reply is evasive or absent, treat that as information. Some third-party testing organisations also publish analyses of popular products.
Medical disclaimer. This article is general information for adults, not medical advice. These statements have not been evaluated by the Food and Drug Administration, and MemoHoney is not intended to diagnose, treat, cure or prevent any disease. Speak with a qualified healthcare professional before starting any supplement.